Search research articles

Related Concept Videos

Preclinical Development: Overview

Preclinical Development: Overview

Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Emergence of foot-and-mouth disease virus SAT 1 topotype III in Iran: molecular and phylogenetic analysis.

Virus genes·2026

Same author

Cell line engineering for enhanced measles virus production with sphingosine kinase 1 gene overexpression.

Virus genes·2025

Same author

Molecular epidemiology of foot and mouth disease virus in Iran during 2019 and 2023.

Scientific reports·2025

Same author

Molecular Identification, Phylogenetic Analysis, Clinical and Histopathological Findings of Dermocystidium anguillae From Koi Carp (Cyprinus carpio).

Journal of fish diseases·2025

Same author

Comparison of two continuous cell lines BHK-21 and IB-IS2 for isolating field serotypes O and A of Foot-and-Mouth disease virus.

Virus genes·2025

Same author

Molecular characterization and phylogenetic analysis of Cyprinid herpesvirus 3 genotypes in Iran from 2020 to 2023.

Scientific reports·2025

Same journal

Direct Androgen Receptor Antagonism Enhances Therapeutic PSMA Radioligand Uptake in Prostate Cancer Models.

Molecular imaging and biology·2026

Same journal

Advances in PD-L1 Targeted Molecular Imaging Radiotracers Research: From Preclinical Exploration to Clinical Application.

Molecular imaging and biology·2026

Same journal

Preclinical Evaluation of [<sup>18</sup>F]JNJ-1: A Novel Positron Emission Tomography Ligand Targeting AMPAR/TARP γ8.

Molecular imaging and biology·2026

Same journal

Probing Early Myocardial Remodeling in Response to a High-Fat Diet in Mice by Evaluation of Extracellular Volume Fraction Using 4D Retrospectively Gated Micro-CT Imaging.

Molecular imaging and biology·2026

Same journal

Molecular Imaging of Butyrylcholinesterase Associated with Amyloid-β Plaques Distinguishes 5XFAD from Wild-Type Mice: A Proof-of-Concept.

Molecular imaging and biology·2026

Same journal

Brain Amyloid Deposition Is Negatively Associated with Cardiac Amyloid Retention in Apo E4 Carriers: A Pilot Study.

Molecular imaging and biology·2026

See all related articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Video

Updated: Jun 19, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

In Vivo Tracking Modalities for Oncolytic Reovirus: Principles, Clinical Applications, and Translational Integration.

Malihe Rastegarpanah^1,2, Zahra Ziafati Kafi³, Babak Negahdari⁴

¹Department of Medical Biotechnology, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences (TUMS), No. 88, Italy St, Tehran, Iran. rastegarpanah-m@alumnus.tums.ac.ir.

Molecular Imaging and Biology

|April 10, 2026

Summary

This summary is machine-generated.

Tracking oncolytic reovirus (Pelareorep) in cancer therapy requires advanced in vivo imaging and molecular tools. Emerging strategies promise improved monitoring for personalized treatment, bridging preclinical and clinical applications.

Keywords:

In-vivo imaging Molecular imaging Nanoparticle-based theranostics Oncolytic reovirus Pelareorep Virotherapy monitoring

More Related Videos

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Related Experiment Videos

Last Updated: Jun 19, 2026

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Ex Vivo Infection of Live Tissue with Oncolytic Viruses

Published on: June 25, 2011

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Genome-wide RNAi Screening to Identify Host Factors That Modulate Oncolytic Virus Therapy

Published on: April 3, 2018

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Radionuclide-fluorescence Reporter Gene Imaging to Track Tumor Progression in Rodent Tumor Models

Published on: March 13, 2018

Area of Science:

Oncology
Virology
Medical Imaging

Background:

Oncolytic reovirus, exemplified by Pelareorep, shows therapeutic potential in cancer via selective replication in Ras-activated cells and immune modulation.
Effective clinical translation necessitates robust in vivo tracking strategies to monitor viral distribution and therapeutic efficacy.

Purpose of the Study:

To critically evaluate current and emerging in vivo tracking strategies for oncolytic reovirus therapy.
To emphasize the translational relevance and clinical implementation of these tracking methods, particularly for Pelareorep.

Main Methods:

Systematic analysis of preclinical and clinical studies utilizing optical, nuclear, MRI, ultrasound/photoacoustic imaging, molecular reporters, and nanoparticle platforms.
Focused examination of integrated functional imaging and molecular assays in Pelareorep trials.

Main Results:

Optical imaging excels in preclinical settings but faces tissue penetration limits; nuclear imaging offers whole-body clinical translation.
MRI and ultrasound/photoacoustic techniques provide real-time structural and functional visualization.
Nanotechnology and molecular tools (reporter genes, CRISPR, barcoding) enhance resolution and delivery; Pelareorep trials confirm imaging integration feasibility.
Challenges remain, including viral clearance and signal penetration.

Conclusions:

Advanced techniques like synthetic biology reporters, AI image analysis, biosensors, and liquid biopsies offer scalable, patient-specific tracking.
An integrated framework connecting preclinical findings with clinical translation is crucial for optimizing oncolytic reovirus therapy design, monitoring, and personalization.